Registered entities
DIANTHUS THERAPEUTICS, INC.
Reg. No. 84-2257157United States
Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 4 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
Social engagement
Social engagement: 11K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include 5AM Ventures, Fidelity Investments, Avidity Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 2 | 29% |
Hiring activity
Hires periodically
19 roles tracked across 4 of the last 12 months
11 Jun 2026 · Director, Biologics Formulation Development
9 Jan 2026 · Director, Accounting · Lancaster
9 Jan 2026 · Senior Director, Regulatory Affairs · Los Angeles
2 Dec 2025 · Manager, Regulatory Clinical Applications · Syracuse
22 Nov 2025 · Manager / Senior Manager, Drug Safety Operations · Grand Rapids
Based on job postings tracked across public sources.
Recent activity
29 Jun 2026
Product launch
Phase 3 EMERGE trial of claseprubart in generalized Myasthenia Gravis (gMG)
27 Jun 2026
Event
12th Congress of the European Academy of Neurology (EAN)
25 Jun 2026
Milestone
users